Linked research, clinical, and regulatory source pathways.
Company profile
About Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Company description Brook Health official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Brook Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
No customer types are currently listed.
Deployment & integration
Deployment information is currently being developed.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Remote Patient Monitoring Program Components and Short-Term Hypertension Control: Retrospective Cohort Study.JMIR mHealth and uHealth · Mar 24, 2026
Differences in Infection Rates by Surgical Approach in Total Hip Arthroplasty and Patient Sex: A Systematic Review.The Iowa orthopaedic journal · Jan 1, 2022
Efficacy and safety of high versus standard dose ibuprofen for patent ductus arteriosus treatment in preterm infants: A systematic review and meta-analysis.Journal of neonatal-perinatal medicine · Jan 1, 2022
Clinical risk factors for mortality in an analysis of 1375 patients admitted for COVID treatment.Scientific reports · Dec 3, 2021
To Scar or Not to Scar.The New England journal of medicine · Jul 29, 2021
Edible cannabis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · Feb 18, 2020
Clinical validation
Clinical-trial records
The Stony Brook University Calm-Mom StudyNCT04018625 · Sponsor · COMPLETED
Paired VNS For TBI RehabilitationNCT07719829 · Sponsor · NOT YET RECRUITING
Vagus Nerve Stimulation in Patients in Comatose StateNCT07719595 · Sponsor · RECRUITING
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in SchizophreniaNCT07715253 · Sponsor · NOT YET RECRUITING
A Multimodal Imaging Study of Dopamine in Early PsychosisNCT06977308 · Sponsor · NOT YET RECRUITING
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsNCT05503797 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Brook Health
Recent articles published on Brook Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.